Company intelligence / Profile preview

CGG

Ownership: Private
Employees: ~3300
Development stage: Commercial

Overview

CGG, historically known for geoscience and industrial computing, has entered the healthcare/life sciences sector by providing high-performance computing (HPC), artificial intelligence (AI), and cloud-based data analytics services. In 2023, it became the exclusive HPC cloud partner of Biosimulytics—a pharmatech company using AI to accelerate new drug development. Through this partnership, CGG enables pharmaceutical companies worldwide to leverage predictive simulation capabilities that can shorten time-to-market and reduce risk in developing new medicines. The company’s expertise lies in scaling complex scientific workflows at industrial scale (>350 petaflops), now applied beyond energy/mining into precision medicine R&D[1].

Industry: Drug Discovery Services

Partnerships

Biosimulytics (exclusive HPC/AI/cloud provider for their pharmatech platform)[1]

Beyond the preview

Go deeper on CGG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CGG.

Explore the full profile